Skip to main content
NACFC 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded Session
Recorded Session
Livestreamed Session
Livestreamed Session
Session is Ticketed (Add-on Session through Registration)
Session is Ticketed (Add-on Session through Registration)
Food Available for Session Attendees
Food Available for Session Attendees
Session includes an in person invitee/speaker with CF
Session includes an in person invitee/speaker with CF

Nicole Mayer-Hamblett, PhD

University of Washington


Nicole Mayer Hamblett, PhD, is a Professor of Pediatrics and Adjunct Professor of Biostatistics at the University of Washington. She is the Co-Executive Director of the Cystic Fibrosis Therapeutics Development Network (CF TDN) Coordinating Center at Seattle Children’s Research Institute. She has led the design and analysis of numerous large multicenter clinical studies which have advanced clinical care and outcomes in CF. Dr. Hamblett collaborates on regulatory strategy for complex drug development issues relevant to rare diseases. She is currently a principal investigator on therapeutic trials optimizing treatment regimens in CF, studies to advance biomarkers supporting therapeutic development for novel CFTR modulator therapies, and methodologic work to innovate clinical trials for rare diseases,in particular to support a pipeline of nucleic acid based therapies for people with CF ineligible for CFTR modulators. She serves on a number of national scientific advisory committees for the Cystic Fibrosis Foundation and is an advisory committee member for the Food and Drug Administration.

Presentation(s):